Screening and treatment of diabetic nephropathy by primary care physicians

Journal of General Internal Medicine

Volumn 14, Issue 2, 1999, Pages 88-97

  Kraft, Stephanie Kakos ^a   Lazaridis, Emmanuel N ^a,b   Qiu, Chunfu ^a   Clark Jr , Charles M ^a,b,c   Marrero, David G ^a,b,d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b REGENSTRIEF INSTITUTE   (United States)

^c RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Diabet Research and Training Center   (United States)

Author keywords

Diabetic nephropathy; Practice patterns; Primary care physicians; Survey

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN;

ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GENERAL PRACTITIONER; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MEDICAL SPECIALIST; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA; SCREENING;

CLINICAL COMPETENCE; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; INDIANA; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MASS SCREENING; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; SPECIALTIES, MEDICAL; TREATMENT OUTCOME;

EID: 0032973098     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1497.1999.00292.x     Document Type: Article

References (22)

1. Nelson RG, Knowler WC, Pettitt DJ, Bennett PH. Kidney diseases in diabetes. In: National Diabetes Data Group. Diabetes in America. 2nd ed. Bethesda, Md: National Institutes of Health; 1995: 349-85. NIH publication No. 95-1468.
2. Diabetes Control and Complications Trial Research Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int. 1995;47:1703-20.
3. American Diabetes Association. Treatment of hypertension in diabetes. Diabetes Care. 1993;16:1394-401.
4. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med. 1993;118:577-81.
5. Mathiesen ER, Hommel E, Giese J, Parving HH. Efficacy of captopril in postponing nephropathy in normotensive insulin-dependent diabetic patients with microalbuminuria. BMJ. 1991;303:81-7.
6. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993;329:1456-62.
7. Rodby RA, Firth LM, Lewis EJ. The Collaborative Study Group. An economic analysis of captopril in the treatment of diabetic nephropathy. Diabetes Care. 1996;19:1051-61.
8. Bjorck S, Mulec H, Johnsen SA, Norden G, Aurell M. Renal protective effect of enalapril in diabetic nephropathy. BMJ. 1992;304: 339-43.
9. Ravid M, Savin H, Jutrin I, Bental T, Lang R, Lishner M. Long term effect of ACE inhibition on development of nephropathy in diabetes mellitus type II. Kidney Int. 1994;45:S161-4.
10. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 1996;19:S8-15.
11. Consensus development conference on the diagnosis and management of nephropathy in patients with diabetes mellitus: position statement. Diabetes Care. 1994;17:1357-61.
12. Cook PJ, Mizer KL. The Revised ERS County Typology: An Overview. Washington, DC: Rural Economy Division, Economic Research Service, US Department of Agriculture; 1989. Rural Development Report 89.
13. Greenwald HP, Hart LG. Issues in survey data collection on medical practice: some empirical comparisons. Public Health Rep. 1986; 101:540-6.
14. Siebert C, Lipsett LF, Greenblatt J, Silverman RE. Survey of physician practice behaviors related to diabetes mellitus in the U.S., 1: design and methods. Diabetes Care. 1993;42:759-64.
15. Schucker S, Wittes JT, Cutler JA, et al. Change in physician per spective on cholesterol and heart disease: results from two national surveys. JAMA. 1987;258:3521-6.
16. Montaño DE, Phillips WR. Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit. Am J Public Health. 1995; 85:795-800.
17. Kraft SK, Marrero DG, Lazaridis EN, Fineberg N. Qiu C, Clark CM. Primary care physicians' practice patterns and diabetic retinopathy: current levels of care. Arch Fam Med. 1997;6:29-37.
18. Stolar MW. Clinical management of the NIDDM patient: impact of the American Diabetes Association practice guidelines, 1985-1993. Diabetes Care. 1995;18:701-7.
19. Miller KL, Hirsch IB. Physicians' practices in screening for the development of diabetic nephropathy and the use of glycosylated hemoglobin levels. Diabetes Care. 1994;17:1495-7.
20. Deeb LC, Pettijohn FP, Shirah JK, Freeman G. Interventions among primary-care practitioners to improve care for preventable complications of diabetes. Diabetes Care. 1988;11:275-80.
21. Kenny SJ, Smith PJ, Golschmid MG, Newman JM, Herman WH. Survey of physician practice behaviors related to diabetes mellitus in the US. Physician adherence to consensus recommendations. Diabetes Care. 1993;16:1507-10.
22. Lomas J, Anderson GM, Domnick-Pierre K, Vayda E, Enkin MW, Hannah WJ. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med. 1989;321:1306-11.